Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of PTC Therapeutics's Vincerinone?
Vincerinone is a small molecule commercialized by PTC Therapeutics, with a leading Phase III program in Subacute Necrotizing Encephalomyelopathy (Leigh...
Data Insights
Risk adjusted net present value: What is the current valuation of PTC Therapeutics's Vincerinone?
Vincerinone is a small molecule commercialized by PTC Therapeutics, with a leading Phase III program in Epilepsy. According to Globaldata,...